BIOCRYST PHARMACEUTICALS INC 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Jul 21, 2009
Insider Transaction Report
Form 4
Mills Mike
Principal Accounting Officer
Transactions
- Sale
Common Stock
2009-07-17$6.00/sh−968$5,808→ 0 total
Footnotes (1)
- [F1]Sold pursuant to a Rule 10b5-1 plan.